Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Verastem, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- −13 vs. Q2 2022
- Shares held
- 127.4M
- +17.7M (+16.2%) vs. Q2 2022
- Total value
- $108.2M
- −$19.0M (−14.9%) vs. Q2 2022
- New holders
- 8
- 29 more added
- Sold out
- 21
- 30 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VSTM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $363.5M |
| Q1 2026 | 155 | $431.5M |
| Q4 2025 | 143 | $590.6M |
| Q3 2025 | 118 | $526.5M |
| Q2 2025 | 111 | $218.3M |
| Q1 2025 | 100 | $261.0M |
| Q4 2024 | 92 | $175.9M |
| Q3 2024 | 77 | $79.5M |
| Q2 2024 | 68 | $43.5M |
| Q1 2024 | 70 | $199.0M |
| Q4 2023 | 58 | $135.8M |
| Q3 2023 | 57 | $136.2M |
| Q2 2023 | 61 | $119.9M |
| Q1 2023 | 80 | $40.5M |
| Q4 2022 | 89 | $42.0M |
| Q3 2022 | 109 | $108.2M |
| Q2 2022 | 123 | $127.2M |
| Q1 2022 | 140 | $162.7M |
| Q4 2021 | 153 | $241.8M |
| Q3 2021 | 147 | $354.8M |
| Q2 2021 | 152 | $468.7M |
| Q1 2021 | 135 | $246.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Verastem, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 3,244,650 | $2.76M | 0.65% | 00.0% | Unchanged |
| BlackRock Inc. | 4,274,502 | $3.63M | 0.00% | −62,832−1.4% | Reduced |
| Wellington Management Group LLP | 4,467,491 | $3.80M | 0.00% | +4,096,738+1,105.0% | Added |
| Eagle Asset Management Inc | 5,369,029 | $4.56M | 0.03% | −202,604−3.6% | Reduced |
| Vanguard Group Inc | 8,511,513 | $7.24M | 0.00% | +528,022+6.6% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 9,224,000 | $7.84M | 0.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 17,200,000 | $14.6M | 0.29% | +17,200,000 | New |
| BVF Inc | 19,974,658 | $17.0M | 0.70% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 26,988,898 | $22.9M | 0.15% | 00.0% | Unchanged |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −1,590,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −228,023−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −182,391−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −63,940−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −60,814−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −51,331−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −41,048−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −25,633−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −23,500−100.0% | Sold out |
| Kalos Management, Inc. | 0 | $0 | 0.00% | −20,750−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,937−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,965−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,957−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −10,102−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,110−100.0% | Sold out |
| Evermay Wealth Management LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −352−100.0% | Sold out |
| Brewin Dolphin Wealth Management Ltd | – | – | – | – | Not filed |